Background: Reviews assessing the genetic basis of ciprofloxacin resistance in Escherichia coli have mostly been qualitative. However, to predict resistance phenotypes based on genotypic characteristics, it is essential to quantify the contribution of genotypic determinants to resistance.
Introduction
Escherichia coli is a Gram-negative bacterium that is able to adopt a commensal or pathogenic lifestyle in humans and animals. 1 Adding to the danger of pathogenic E. coli is the rise of antimicrobial resistance. E. coli has acquired resistance to some of our most important antimicrobials, including aminopenicillins, cephalosporins, aminoglycosides, carbapenems and fluoroquinolones. 2 Ciprofloxacin is an antimicrobial of the fluoroquinolone class, commonly prescribed for a wide variety of infections, including those caused by E. coli. 3 As is the case for other fluoroquinolones, the substrate of ciprofloxacin is the complex formed by the DNA of the bacterium and either the DNA gyrase enzyme or the topoisomerase IV enzyme. [4] [5] [6] DNA gyrase creates single-stranded breaks in the DNA to supercoil negatively the DNA during replication or transcription. 7 If ciprofloxacin binds DNA gyrase in complex with DNA, the single-stranded DNA breaks cannot be re-ligated and thus accumulate, leading to double-stranded DNA breaks. 8 A similar mechanism is hypothesized for topoisomerase IV. 9 The mechanisms of ciprofloxacin resistance in E. coli have been investigated intensively in the past 30 years. Mutations in genes coding for DNA gyrase and topoisomerase IV contribute to ciprofloxacin resistance in E. coli. 10, 11 In addition, efflux pumps may decrease drug accumulation while peptides and enzymes may block drug targets or may modify the drug, respectively (Figure 1 ). Numerous reviews have covered the topic of ciprofloxacin resistance in E. coli, but these reviews have been overwhelmingly qualitative in nature. [12] [13] [14] [15] [16] [17] [18] [19] V C The Author(s) 2018. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved. For permissions, please email: journals.permissions@oup.com.
With the rapidly increasing availability of next generation sequencing technologies, research aimed at the prediction of a resistance phenotype from genomic data is increasing. However, these efforts typically correlate genotypic data with a categorical measure of resistance, whereas a quantitative resistance phenotype prediction is of clinical relevance. Therefore, we carried out a systematic review, summarizing observational and experimental studies that assessed genetic ciprofloxacin resistance determinants and the ciprofloxacin MIC conferred by these determinants in E. coli, to elucidate how the presence of genomic resistance determinants, either alone or in combination, affects ciprofloxacin MIC in E. coli. In addition, we performed an E. coli protein network analysis to detect potential additional determinants of ciprofloxacin resistance based on the findings of the systematic review.
Methods

Systematic search
The PRISMA 2009 checklist was used as a guide for this systematic review. 20 PubMed and Web of Science were searched using a defined set of keywords, selecting original research articles in English reporting on susceptibility test results (MICs) for E. coli isolates caused by genetic modifications identified in clinical, carriage or environmental isolates (observational) or introduced in E. coli strains in vitro (experimental). For details, see the Supplementary methods, available as Supplementary data at JAC Online). No time limits were applied. In addition to the defined search strategy, forward and backward citation searches of reviews and included articles were carried out. The final search was conducted on 5 July 2018.
Inclusion and exclusion criteria for experimental and observational studies
Articles were not considered eligible for inclusion if they failed to mention any keyword (listed in the Supplementary methods) describing ciprofloxacin resistance determinants in the title or abstract. Eligible articles were screened by title, abstract and/or full text for inclusion based on the following inclusion and exclusion criteria (Figure 2 ). Studies could be included as experimental or as observational studies. For inclusion as an experimental study, the study needed to report a ciprofloxacin MIC before and after the introduction of a genetic modification in a single E. coli strain. Studies were eligible to be included as observational studies if the ciprofloxacin MIC for at least one E. coli isolate was reported, together with the observed genetic determinants of ciprofloxacin resistance. In vitro evolution studies where E. coli was exposed to ciprofloxacin resulting in decreased susceptibility to ciprofloxacin were considered observational studies, as mutations are not actively introduced in these studies. Observational studies were excluded if they failed to test for the presence of all of the following resistance determinants: mutations in Ser83 and Asp87 of gyrA, mutations in Ser80 and Glu84 of parC, mutations in acrR and marR, presence of oqxAB, qepA, qnrA, qnrB, qnrS and aac(6 0 )Ib-cr. If studies failed to indicate unambiguously which resistance determinants were tested, the study was excluded.
Definitions
For this systematic review, the conventional definition of MIC was used, meaning the lowest concentration of ciprofloxacin that inhibits the visible growth of a bacterial culture during overnight incubation. 21 Clinical breakpoints (0.25 mg/L susceptible; 0.5 mg/L intermediately resistant, 1 mg/L resistant) and epidemiological cut-offs (0.064 mg/L) were used as defined by EUCAST. 22, 23 A genomic resistance determinant was defined as a mutation in a gene or the presence of a plasmid-mediated gene that decreases ciprofloxacin susceptibility. As currently four mechanisms of ciprofloxacin resistance in E. coli are known, an isolate can possess multiple resistance determinants encoding for multiple resistance mechanisms. In addition, a single resistance mechanism can be encoded by multiple resistance determinants.
Genetic modifications were defined as an experimentally acquired mutation, insertion or deletion of a nucleotide or a sequence of nucleotides in the chromosome. The introduction of plasmid-mediated genes was also considered a genetic modification. Dominance tests as described by Heisig and Wiedemann 24 were considered experimental evidence. In short, a dominance test relies on increasing the susceptibility of a bacterium to an antimicrobial, by introducing a plasmid containing the WT gene that codes for the antimicrobial's target. In the studies included in this report, the MICs of bacteria with mutations in gyrA or parC were lowered by introducing a plasmid containing WT gyrA or parC. Systematic review
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Data extraction and analysis
The management of the literature search was performed using Pubreminer (http://hgserver2.amc.nl/cgi-bin/miner/miner2.cgi). All data on genetic modifications were extracted from the articles or supplementary material, together with MIC data. For experimental data, the MICs of the isolates before and after a targeted genetic modification were extracted to calculate a fold change of ciprofloxacin MIC for each of the E. coli isolates.
We calculated how frequently resistance determinants were tested in the experimental data. This frequency is expressed as the number of isolates in which the genetic modification was introduced, divided by the total number of isolates included from experimental studies. The frequency can be used to estimate the strength of evidence per resistance determinant (Table S1 ). Furthermore, the sample sources, country of origin and isolation date of included E. coli isolates were extracted from the observational studies.
The MIC fold change data plot and the correlation matrix were generated using the ggplot2 package RStudio version 1.1.383, running R version 3.4.2. Pearson correlation coefficients were calculated using the stats package and prepared for plotting using the reshape2 package.
Network construction
To investigate interactions between resistance determinants and to search for potential resistance determinants, a protein-protein interaction (PPI) network was constructed. The E. coli K-12 MG1655 interactome was extracted from the STRING-v10 database. 25 String-v10 aims to be more complete in terms of coverage of proteins for each organism in comparison to the other meta-interactomes available. 26, 27 The functional association is the basic interaction unit of String to link proteins with a functional relation that are likely to contribute to a common biological purpose. Each interaction is derived from multiple sources, and we identify three groups of Systematic review interactions (Table S2) : protein interactions (PIs; where at least one physical PI has been tested, imported from primary databases), functional prediction interactions (FPs; determined by at least one FP of an algorithm employed by String, genomic information, pathway knowledge, orthology relations) and text-mining interactions (TMs; supported only by automated TM of MedLine abstracts and full-text articles). Based on the sources, for each interaction in String a score is calculated, ranging from 0 to 1. In our analysis, only interactions with a score .0.7 were retained (defined as highquality interactions by String), resulting in 3890 nodes and 32 854 edges (with only 0.06% of the links supported only by TM interactions). Genes resulted by the systematic search were mapped to the EcoGene-3.0 database to obtain E. coli K-12 MG1655 identifiers (bnumber) 28 that were subsequently mapped to the MG1655 interactome.
Results
Systematic search
The systematic search yielded 5055 PubMed entries and 5873 Web of Science entries. After removal of duplicates, 1718 unique articles were screened on content by title, abstract and, if necessary, full text. This approach identified 50 articles that were included as experimental studies. Additionally, 10 experimental studies were identified through backward/forward searches in citations of included articles and known reviews. Three articles fulfilled inclusion criteria for observational studies, of which two articles were also included as experimental studies because they provided experimental data as well ( Figure 2 ).
The number of E. coli isolates that were confirmed to harbour at least one resistance determinant and for which MICs were reported, amounted to a total of 366 isolates from experimental studies (Table S1 ) and 238 isolates from observational studies (Table S3 ). A total of 43 different genomic determinants were described in the collected experimental data, of which 21 were shown to have an effect on ciprofloxacin MIC (Table 1) .
Experimental studies focused primarily on mutations in Ser83 (28% of included isolates) and Asp87 (18%) of gyrA, S80 (15%) of parC and mutations in marR (20%). Of all plasmid-mediated resistance genes, qnrA (17%), qnrS (12%) and aac(6 0 )Ib-cr (13%) were described most often. The other resistance determinants were tested in ,10% of the experimentally modified isolates.
Target alteration mutations in gyrA, gyrB, parC and parE
Mutations in gyrA were the first ciprofloxacin resistance determinants to be discovered. 12 Mutations in parC, gyrB and parE were later also proven or implied to decrease ciprofloxacin susceptibility.
11, 29, 44 gyrA and parC mutations that reduce ciprofloxacin susceptibility cluster in regions termed the quinolone resistance-determining regions (QRDRs). Generally, the QRDR of gyrA ranges from amino acid Ala67 to Gln106, 45 and the QRDR of parC from Ala64 to Gln103.
11 gyrA and parC mutations accumulate stepwise in E. coli when exposed to ciprofloxacin, increasing ciprofloxacin MIC concurrently.
11, [46] [47] [48] The most common initial mutation is Ser83Leu in gyrA. [46] [47] [48] In the collected experimental data, this mutation confers a median increase in MIC of 24-fold compared with the WT (range: 4-133-fold increase).
11, [49] [50] [51] [52] [53] [54] [55] This mutation is most often followed by Ser80Ile in parC 11,46,48 and finally by Asp87Asn or Asp87Gly in gyrA. [46] [47] [48] As mutations in gyrA and parC accumulate, ciprofloxacin MIC increases steeply. The ciprofloxacin MIC fold increase for a mutant of Ser83Leu (gyrA) and Ser80Ile (parC) is 62.5. 51 A similar double mutant of Ser83Leu (gyrA) and Ser80Arg (parC) showed a ciprofloxacin MIC fold increase of 125. 53 For a triple mutant of Ser83Leu, Asp87Asn (gyrA) and Ser80Ile (parC) the median ciprofloxacin MIC fold increase is 2000.
11,51,54 A quadruple mutant of Ser83Leu, Asp87Asn (gyrA) and Ser80Ile, Glu84Lys (parC) has been tested, but this mutant did not show a higher ciprofloxacin MIC than triple mutants within the same study.
11 In addition, Gly81Asp and Asp82Gly mutations in gyrA have been tested. These mutations caused low to no decrease in ciprofloxacin susceptibility (MIC changes: 2.6-and 1-fold, respectively; Table 2 ). 49, 56 Only one gyrB mutation (Asp426Asn) was shown to slightly increase ciprofloxacin resistance (Table 2) . 29 We did not find studies that showed decreased ciprofloxacin susceptibility due to mutations in parE. However, a Leu445His mutation in parE of E. coli caused a 2-fold increase in the MIC of norfloxacin, another fluoroquinolone. 44 Efflux pump genes (acrAB, tolC) and their transcriptional regulators (marR, acrR and soxS)
As with many other antimicrobials, bacterial efflux pumps also play a role in resistance to ciprofloxacin. Deletion of acrAB or tolC confers a clear increase in the ciprofloxacin susceptibility of E. coli (4-8-fold decrease in MIC). 30, 31, 57 Deletions of 14 other genes or operons coding for efflux pumps in E. coli did not affect the ciprofloxacin MIC. 31 The deletion of transcriptional repressors of expression of efflux pumps, e.g. marR and acrR has been shown to affect ciprofloxacin MIC. The only study in our collected experimental data to investigate deletion of acrR showed that the MIC tripled after the repressor was deleted. 51 Nine studies investigated the effects of marR deletion or mutation, which reported a median The only genes displayed are those that were shown to have any effect on ciprofloxacin susceptibility when mutations are present (chromosomal genes) or if the resistance gene is present (plasmid-encoded genes).
Systematic review 33 detected mutations in rpoB in an in vitro evolution experiment. These mutations arose after accumulation of other mutations, and were shown to increase the ciprofloxacin MIC of a WT E. coli by 1.5-3-fold ( Table 2 ). The mutations in rpoB were shown to increase ciprofloxacin MIC by upregulating the expression of mdtK (also known as ydhE).
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Two experimental studies reported mutations in efflux pump operons influencing ciprofloxacin MIC. The first mutation was Ala12Ser in soxS, leading to higher expression of acrB, in turn leading to a 4-fold increase in ciprofloxacin MIC. 32 The second mutation was a Gly288Asp mutation in acrB itself, conferring a 16.7-fold increase in ciprofloxacin MIC (Table 2) . 61 This acrB mutation, however, increased susceptibility to other antimicrobials.
Plasmid-encoded efflux pump genes oqxAB and qepA
In addition to chromosomally encoded efflux pumps, the presence of plasmid-encoded efflux pump genes oqxAB and qepA has been shown to increase ciprofloxacin MIC in E. coli. 34, 35 oqxAB confers a median increase in MIC of 7.5-fold (range: 2-16-fold increase), 35, [62] [63] [64] while qepA confers a median increase of 4.5-fold (range: 2-31-fold increase; Table 2 ). 34, 52, [65] [66] [67] [68] qnr genes qnrA was the first plasmid-mediated quinolone resistance determinant to be discovered. 36 Qnr proteins are pentapeptide repeat proteins that decrease binding of fluoroquinolones to DNA gyrase by binding the DNA/DNA gyrase complex. 69 Since 2002, many more qnr alleles have been discovered. Currently seven families of qnr genes are recognized: qnrA, qnrB, qnrC, qnrD, qnrE, qnrS and qnrVC. 70 In the collected experimental data, all qnr families have been tested for their influence on ciprofloxacin MIC in E. coli, except for qnrVC. qnr genes confer ciprofloxacin MIC increases between 4-and 125-fold. The median ciprofloxacin MIC fold increase differed by qnr allele (Table 2 ).
aac(6 0 )Ib-cr and crpP
A plasmid-mediated mutant aac(6 0 )Ib gene that decreased fluoroquinolone susceptibility in E. coli was discovered in 2006. 42 Until then, aac(6 0 )Ib genes were only known to decrease E. coli susceptibility to aminoglycosides. A double mutation in the acetyltransferaseencoding gene enabled the resulting protein to acetylate both aminoglycosides and some fluoroquinolones, including ciprofloxacin. This novel variant, aac(6 0 )Ib-cr, was shown to confer a median increase in ciprofloxacin MIC of 6.9-fold (range: 1-62.5-fold increase; Table 2 ).
52,71-76
The most recently discovered ciprofloxacin resistance determinant in E. coli is crpP, a plasmid-mediated gene coding for a protein with the putative ability to phosphorylate certain fluoroquinolones, e.g. ciprofloxacin. 43 crpP was first detected in a clinical isolate of Pseudomonas aeruginosa, but was shown to confer a 7.5-fold increase in ciprofloxacin MIC when conjugated to E. coli J53.
Effect of multiple modifications on MIC
The fold change in MIC of each included experimental isolate was plotted, stratified for the resistance mechanism present (Figure 3 ). Target alteration resulted in the largest range of MIC fold changes, which were on average higher than the fold changes observed because of the three other mechanisms. While the presence of determinants representing different ciprofloxacin resistance mechanisms may result in a moderate fold change in MIC, the accumulation of multiple resistance determinants encoding multiple mechanisms of resistance is likely to increase the ciprofloxacin MIC significantly.
Data on plasmid-mediated resistance genes come from either resistance genes cloned into typical lab vectors (e.g. pUC18), or the genes can be tested in their 'native' plasmid. Generally, lab plasmids have higher copy numbers, which could bias results when resistance genes cloned into lab plasmids are compared with resistance genes in their native plasmids. To assess this possible difference, we extracted information about the plasmids used in all experimental isolates, in which the effect of a single plasmidmediated resistance gene was tested. For three mechanisms (efflux, physical blocking and enzymatic modification), we compared the ciprofloxacin MIC fold change conferred by the resistance genes compared between native (n " 97) and cloned (n " 70) plasmids ( Figure S1 ). This analysis indicated that resistance genes cloned into lab plasmids did not confer higher MIC fold changes than resistance genes in native plasmids, when stratified per mechanism.
Comparison of experimental and observational data
We compared the findings from the experimental data with susceptibility test results and associated presence of mutations reported for isolates in observational studies. Because studies Systematic review JAC were excluded if isolates were not tested for the presence of all known resistance encoding determinants, only studies could be included that were published after oqxAB was linked to increased ciprofloxacin MIC in 2007. 35 The description of crpP was only recently published and was therefore not used as an inclusion criterion. Only three observational studies reported on the presence of all currently known resistance determinants. 33, 97, 98 As mutations in both acrR and marR genes were shown to result in no to low fold changes in ciprofloxacin MIC, we added five observational studies that fulfilled all inclusion and exclusion criteria except testing for the presence of mutations in acrR and marR genes, in a secondary analysis. Thus, eight observational studies published between 2012 and 2018 were included, contributing data on a total of 238 strains (Table S3 ). The studies reported data on 1-92 isolates, with a median of 13.5 isolates per study. Ciprofloxacin MICs of included isolates ranged from 0.015 to 1024 mg/L with a median MIC of 1 mg/L.
We analysed MIC distributions for combinations of resistance determinants that were reported at least five times in the experimental and observational data. These combinations of resistance determinants included the mutation Ser83Leu in gyrA, presence of qnrS1 and presence of aac(6 0 )Ib-cr. Although for most combinations of resistance determinants small numbers of isolates were reported, results of experimental and observational data appear comparable with the exception of the reported MICs for E. coli strains solely harbouring aac(6 0 )Ib-cr (Table 3) . We also examined if certain combinations of resistance mechanisms were more prevalent than others in the observational data. Calculating Pearson correlation coefficients between commonly observed resistance determinants showed that gyrA (Ser83, Asp87) and parC (Ser80) mutations were positively correlated with each other. Additionally, these three mutations were shown to correlate inversely with the presence of qnrB and qnrS genes in our observational data. This inverse correlation was not observed with other frequently reported plasmid-mediated resistance determinants, e.g. aac(6 0 )Ib-cr (Figure 4 ).
Network visualization
To obtain a global picture of the mutation landscape associated with ciprofloxacin resistance, we mapped the selected chromosomal genes onto a PPI network. The selected genes were evaluated in a wide range of E. coli strains, and we mapped them to the String-v10 database referring to the E. coli K-12 MG1655 model organism, as it showed the highest number of matching edges and nodes among the strains available in the String database. We Figure 3 . Median fold change (IQR) in ciprofloxacin MIC for each resistance mechanism or combination of resistance mechanisms experimentally tested in 335 isolates. Fold changes were calculated by dividing the MIC after modification by the MIC before modification for each isolate. Data points represent single E. coli isolates. Darker fill of data points indicates the presence of multiple resistance mutations or resistance genes in the isolate. Isolates that showed a decreased ciprofloxacin MIC after modification (e.g. deletion of acrAB or tolC) are not shown but are listed in Table S1 (n " 31). 30, 31, 57 TA, target alteration (mutations in gyrA, gyrB or parC); EP, efflux pump (mutations in acrB, marR, acrR, rpoB or presence of qepA or oqxAB); PB, physical blocking (presence of qnrA, qnrB, qnrC, qnrD, qnrE or qnrS); EM, enzymatic modification [presence of aac(6 0 )Ib-cr or crpP].
Systematic review noted that plasmid-associated genes, e.g. oqxAB and the qnr gene family were not described by interactomes in general, as interactomes mostly describe the core genome. Moreover, some genes (e.g. yohG) could not be mapped because they are not present in E. coli K-12 MG1655. Of the 43 selected genes, 31 (72%) mapped to the PPI network, resulting in a fully connected sub-module. The network highlighted the close relationship between gene connectivity and ciprofloxacin resistance effects: the chosen visualization algorithm showed that genes with similar effects tightly grouped in the interactome ( Figure 5 ). In particular, the genes that had an increasing effect on ciprofloxacin resistance when mutated seemed to cluster, even if the genes belonged to different resistance mechanisms. As expected, close relationships between particular sets of genes were revealed. Transcriptional regulators, e.g. marR, acrR and soxS were shown to interact with efflux pump genes, e.g. acrA, acrB, acrD, acrF and tolC. In addition, the physical interactions between gyrA, gyrB and parC were depicted in the network.
Discussion
This report provides a comprehensive and systematic analysis of 66 papers linking the E. coli genotype to a quantitative ciprofloxacin resistance phenotype, spanning the years 1989-2018 and amounting to a total of 604 isolates. Ciprofloxacin MIC in E. coli is largely affected by target mutations in specific residues in gyrA (Ser83 and Asp87) and parC (Ser80), conferring median MIC increases ranging from 24-fold for single Ser83Leu (gyrA) mutants to 1533 for triple Ser83Leu, Asp87Asn/Gly (gyrA) Ser80Ile/Arg (parC) mutants. However, accumulation of multiple resistance determinants, including those representing other resistance mechanisms, can increase ciprofloxacin MIC even further, up to MIC increases of 4000-fold.
Beside the MIC fold changes that are conferred by resistance determinants, it is important to consider how these genetic resistance determinants are acquired. Various pathways leading to mutagenesis are known in E. coli. First and foremost, spontaneous mutagenesis leads to the accumulation of mutations at a rate of 2.5%10
#3 per genome per replication, although more recent studies have observed mutation rates as low as 1%10
#3 per genome per replication. 99, 100 Additionally, a subset of E. coli isolates displays a higher mutation rate because of mutS or mutL mutations. 100 Finally, specific mechanisms exist that induce mutagenesis. One such mechanism is the SOS response, which is induced after DNA damage inflicted by exogenous substances, including quinolones, e.g. ciprofloxacin. 101 Two proteins that are central in the SOS response are LexA and RecA. In the absence of DNA damage, LexA dimers are bound to an SOS box (promoter region of SOS genes) and inhibit expression of SOS genes. If DNA damage is induced, e.g. through the presence of ciprofloxacin, RecA will bind the ssDNA that is a result of the DNA damage. The activated RecA in turn mediates the self-cleavage of LexA, derepressing the SOS box, finally leading to expression of SOS genes and thus the SOS response. This SOS response induces mutations, among other effects, through DNA damage repair performed by error-prone DNA polymerases. 102 Currently, four ways are known in which the SOS response affects ciprofloxacin resistance in E. coli. First, the SOS response induces a higher mutation rate, making it more likely that ciprofloxacin resistance mutations will arise within a fixed population. 103 Additionally, if the SOS response is knocked out in E. coli, the ciprofloxacin MIC decreases. Clinically resistant E. coli that had Figure 4 . Matrix displaying Pearson correlation coefficients calculated between resistance determinants in a pairwise manner. All 238 strains used for this analysis were screened for all displayed resistance determinants. Reported frequencies of resistance determinants in our dataset are displayed on the y-axis. Full data are provided in Table S3 .
Systematic review JAC recA knocked out showed MIC decreases of 4-8-fold. 103 Furthermore, the SOS response has been shown to induce expression of some qnr gene families, e.g. qnrB and qnrD. 104, 105 Finally, the SOS response has been shown to promote the horizontal gene transfer of an integrative conjugative element SXT in Vibrio cholerae and recombinant E. coli harbouring genes encoding resistance to chloramphenicol, sulphonamides, streptomycin and trimethoprim in the presence of ciprofloxacin. 106 After mutagenesis through mechanisms, e.g. the SOS response, the fitness of the mutant indicates how likely the bacterium is to survive. In the absence of ciprofloxacin, gyrA mutations and parC mutations have been shown to confer limited fitness costs compared with other resistance determinants. 48, 51, 59, 67, 75 Additionally, mutations in gyrA and parC show positive epistasis, as the MIC fold change of the triple Ser83Leu, Asp87Asn (gyrA) and Ser80Ile (parC) mutant is higher (2000-fold increase) than would be expected based on the MIC fold changes conferred by the individual mutations (24-, 16-and 1-fold increases, respectively). 51, 107 This epistatic effect thus raises ciprofloxacin MIC very efficiently. This, in combination with the low fitness costs in the absence of ciprofloxacin might explain why ciprofloxacin resistance mutations in gyrA and parC are the most common ciprofloxacin resistance determinants observed in E. coli. Notably, other combinations of resistance determinants also show positive epistatic effects, although the observed effects are weaker. A similar positive epistatic effect was observed for chromosomal gyrA/parC mutations together with plasmidmediated resistance determinants qepA 67 and aac(6 0 )Ib-cr.
52,75
However, experimental studies of combinations of gyrA and parC mutations with qnr genes showed discordant results. One study reported a negative epistatic effect on the ciprofloxacin MIC of target alteration mutations with all qnr genes tested (qnrA, qnrB, qnrC, qnrD, qnrS) 59 and another study observed a similar effect of target alteration mutations with qnrB, but the opposite effect for target alteration mutations with qnrS in terms of conferred MIC. Network of E. coli ciprofloxacin resistance-associated chromosomal genes. Thirty-one genes that were examined for their influence on ciprofloxacin and were present in the E. coli K-12 MG1655 genome were mapped to the String-v10 PPI database. Colour key: green, mutation conferring increased ciprofloxacin resistance was observed; red, mutation decreased ciprofloxacin resistance; blue, mutation showed no effect on ciprofloxacin resistance. Network is displayed by R package iGraph employing the force-directed layout algorithm by Fruchterman and Reingold. List of edges with corresponding data categories (PI, FP or TM) is available in Table S3 .
Systematic review
The complex relationship between gyrA/parC mutations and qnr genes is further illustrated by our findings from the observational data. We observed a clear negative correlation between the presence of gyrA or parC mutations and presence of qnrB and qnrS genes. This finding is in line with an earlier study that reported an E. coli population fixating gyrA/parC mutations at a reduced rate when the E. coli population harboured a qnr gene as opposed to when the E. coli strain did not harbour a qnr gene. 81 However, no additional fitness costs are usually reported for E. coli harbouring both gyrA/parC mutations and qnr genes. 59 One possible explanation was suggested by the study of Garoff et al., 108 who reported an enhanced fitness cost conferred by qnr genes when Lon protease was absent from an E. coli genome. This finding shows that the fitness cost conferred by an antimicrobial resistance gene to an E. coli strain can be influenced by genes that do not directly play a role in antimicrobial resistance.
By mapping the selected genes onto a known E. coli interactome, we found a clear association between their role in ciprofloxacin resistance and their position in the network, with a significant proximity of genes that produce a similar response in terms of resistance (i.e. increase or decrease). This global picture highlights the presence of common biological functions (mostly associated with the efflux pumps and their regulation), and it suggests that system biology approaches in the future will likely be helpful to identify new targets or specific pathways related to ciprofloxacin resistance or antimicrobial resistance in general. As an example, the position in the network of acrD and acrF genes, which were not identified as resistance-associated genes in the experiments reported so far, and their biological function as efflux pump protein complexes, suggest that their role in resistance should be more deeply investigated.
Despite its comprehensiveness, our study has certain limitations. First, gene expression data are not included in this review because our study aims at the prediction of MIC based on a DNA sequence. It has been shown that increased expression of efflux pumps, e.g. acrAB or transcriptional regulators of efflux pumps, e.g. marA, is significantly correlated with increased fluoroquinolone MIC in E. coli. 109, 110 Secondly, complex combinations of resistance determinants, e.g. combinations of gyrA/parC mutations with plasmid-mediated resistance determinants have been reported sparsely in the experimental data. Therefore, the comparison of experimental and observational data for these combinations of resistance determinants is impossible using this dataset. Finally, only currently known ciprofloxacin resistance determinants could be included in this report. The very recent discovery of crpP suggests that more resistance determinants or resistance mechanisms are still waiting to be discovered. 43 Additionally, complex mutation patterns influencing ciprofloxacin resistance through unknown pathways may exist but current research methods do not usually detect these kinds of effects.
One possible solution for the issues described above would be the use of advanced machine learning algorithms to predict ciprofloxacin resistance. These algorithms should be able to associate large quantities of sequence data with phenotypic metadata in an unbiased manner. One such attempt has been made for ciprofloxacin resistance already. 111 It was reported that Ser83Phe, Ser83Thr (gyrA), Ser80Arg (parC) and presence of any qnr gene were the most important resistance determinants according to the algorithm used. However, this study used categorical (susceptible or resistant) and not quantitative phenotype data, and included various Enterobacteriaceae species and the results can thus not be directly compared with the data presented here for E. coli alone. This is exemplified by the fact that neither Ser83Phe nor Ser83Thr (gyrA) was reported in our observational data. For future studies, the data collected for this review could serve as a benchmark, as this review presents a comprehensive set of quantitative data on the contribution of various resistance determinants to ciprofloxacin MIC in E. coli.
